Impaired Ventilation Is Not Independently Associated with 28-Day Mortality in Coronavirus Disease 2019 (COVID19) Acute Respiratory Distress Syndrome (ARDS)
Luis Morales–Quinteros(Universitat Autònoma de Barcelona), Lieuwe D. J. Bos(Amsterdam Neuroscience), Antonio Artigas(Instituto de Salud Carlos III), David Kaufman(University of Virginia Children's Hospital), Ary Serpa Neto(The University of Melbourne), Michela Botta(Amsterdam University Medical Centers), Lluís Blanch(Universitat Autònoma de Barcelona), Frederique Paulus(Amsterdam University Medical Centers), Anissa M. Tsonas(Amsterdam UMC Location University of Amsterdam), Marcus J. Schultz(University of St.Gallen)
Cited by 1
Related Papers
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
|Critical Care|2013|1.4k
Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis
|JAMA|2003|958
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|737
Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study
|The Lancet Respiratory Medicine|2017|645